Cervical cancer incidence rates considering migration status in mainland China using Bayesian model-Estimation based on 2016 cancer registry data
- PMID: 39853635
- DOI: 10.1002/ijc.35346
Cervical cancer incidence rates considering migration status in mainland China using Bayesian model-Estimation based on 2016 cancer registry data
Abstract
In mainland China, cancer registration relies on household-registered populations, overlooking migrant populations. Estimating cervical cancer incidence among permanent residents, including migrants, offers a more accurate representation of the true burden. The data from 487 cancer registries across China in 2016 were analyzed using a Bayesian spatial regression model with the integrated nested Laplace approximation-stochastic partial differential equation method. The study estimated cervical cancer incidence among household-registered populations and adjusted for migrant populations using a weighting method based on interprovincial distribution and age stratification to derive the incidence of cervical cancer in the permanent residents. Data from the China Population Census, the China Migrants Dynamic Survey, and the Urban Statistical Yearbook were incorporated. The estimated crude incidence rate of cervical cancer among permanent residents was 17.4/100,000 in mainland China, with an age-standardized incidence rate (ASIR) of 17.2/100,000. The largest disparities in cervical cancer crude incidence rate between permanent residents and household-registered populations were observed in Guizhou (2.4/100,000, 95% CI 1.9-2.9/100,000), Zhejiang (-1.2/100,000, 95% CI -1.8 to -0.6/100,000) and Tianjin (-1.1/100,000, 95% CI -1.5 to -0.7/100,000). The number of the estimated cervical cancer incident cases was 8948. Guangdong saw an increase of 887 cases, while Henan had a decrease of 1430 cases. Guizhou had the highest ASIR (28.1/100,000), and Beijing had the lowest ASIR (11.0/100,000). The significance of this study is that it improves the accuracy of cervical cancer data in China. These findings provide evidence for developing cervical cancer prevention and control strategies, and offer insights for other countries and regions facing migration challenges.
Keywords: INLA‐SPDE modeling; cervical cancer; incidence; migrants; permanent residents.
© 2025 UICC.
Similar articles
-
The estimated incidence of uterine corpus cancers among permanent residents in mainland China using Bayesian spatial modeling.Sci Rep. 2025 May 25;15(1):18191. doi: 10.1038/s41598-025-02164-y. Sci Rep. 2025. PMID: 40414901 Free PMC article.
-
[Incidence and mortality of cervical cancer in China, 2014].Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):241-246. doi: 10.3760/cma.j.issn.0253-3766.2018.04.001. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29730908 Chinese.
-
[Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].Zhonghua Fu Chan Ke Za Zhi. 2012 Jun;47(6):445-51. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22932112 Chinese.
-
The burden of cervical cancer in China: synthesis of the evidence.Int J Cancer. 2012 Feb 1;130(3):641-52. doi: 10.1002/ijc.26042. Epub 2011 Jun 10. Int J Cancer. 2012. PMID: 21387308 Review.
-
National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.BMC Public Health. 2023 May 5;23(1):834. doi: 10.1186/s12889-023-15531-z. BMC Public Health. 2023. PMID: 37147640 Free PMC article.
References
REFERENCES
-
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229‐263.
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249.
-
- WHO. Eliminating cervical cancer. https://www.who.int/zh/health-topics/cervical-cancer#tab=tab_2 Accessed June 4, 2024.
-
- AbouZahr C, Boerma T, Hogan D. Global estimates of country health indicators: useful, unnecessary, inevitable? Glob Health Action. 2017;10(suppl):1290370.
-
- Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191‐e203.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical